Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Nephrol Dial Transplant. 2012 Sep;27(9):3516-23. doi: 10.1093/ndt/gfs128. Epub 2012 May 7.
Functional variants in the IL6 gene, in particular the -174G/C polymorphism (rs1800795), affect the mortality risk in dialysis patients. Peritoneal dialysis (PD) patients harbouring the C allele of the -174G/C polymorphism of IL6 showed faster peritoneal transport. The aim of this study was to investigate this IL6 variant as risk factor for mortality and technique failure in a large cohort of Caucasian PD patients.
A Dutch multicentre cohort of 398 incident PD patients (NECOSAD) was analysed. Survival analysis was performed for death and technique failure with a maximum follow-up of 5 years. A combined PD cohort from Amsterdam (Academic Medical Center, N = 71) and Brussels (Université catholique de Louvain Medical School, N = 102) was used for independent replication.
In NECOSAD, 105 patients died on dialysis [incidence rate 10.3/100 person-years (py)], and 138 patients experienced technique failure (16.2/100 py), with peritonitis as important cause. Patients with the C/C genotype had a 71% increased mortality risk compared to patients with the G/G genotype (95% confidence interval 0.98-2.98); this effect was mainly a long-term effect: a 2.7-fold increased mortality risk was found in patients having survived 2 years since the start on dialysis, and a 1.7-fold increased risk for the combined end point (mortality or technique failure). In the combined replication cohort, no increased risks were found in patients with the C/C genotype.
The C/C genotype of the -174G/C polymorphism was associated with an increased mortality risk in 398 Dutch incident PD patients. The existence of substantial differences between the two academic replication cohorts and the discovery cohort from NECOSAD and the limited power of these cohorts prevented an independent replication of the NECOSAD findings.
白细胞介素 6(IL6)基因的功能变体,尤其是 -174G/C 多态性(rs1800795),会影响透析患者的死亡率。携带 IL6-174G/C 多态性 C 等位基因的腹膜透析(PD)患者表现出更快的腹膜转运。本研究旨在调查这一 IL6 变体是否为高加索裔 PD 患者的一个大队列的死亡和技术失败的风险因素。
分析了一个由 398 例新入组 PD 患者组成的荷兰多中心队列(NECOSAD)。采用生存分析对死亡和技术失败进行分析,随访时间最长为 5 年。来自阿姆斯特丹(学术医学中心,N=71)和布鲁塞尔(天主教鲁汶大学医学院,N=102)的联合 PD 队列用于独立复制。
在 NECOSAD 中,105 名患者在透析时死亡[发病率为 10.3/100 人年(py)],138 名患者出现技术失败(16.2/100 py),其中腹膜炎是一个重要原因。与 G/G 基因型患者相比,C/C 基因型患者的死亡率风险增加了 71%(95%置信区间 0.98-2.98);这种影响主要是长期的:在开始透析后存活 2 年的患者中,死亡率风险增加了 2.7 倍,而终点(死亡或技术失败)的风险增加了 1.7 倍。在联合复制队列中,C/C 基因型患者的风险并未增加。
-174G/C 多态性的 C/C 基因型与 398 例荷兰新入组 PD 患者的死亡率风险增加相关。两个学术复制队列与 NECOSAD 发现队列之间存在实质性差异,并且这些队列的效力有限,这使得无法对 NECOSAD 研究结果进行独立复制。